MDMA Therapy Canada

Have traditional approaches left you feeling stuck?

Do you live with daily flashbacks, anxiety, or symptoms of post-traumatic stress disorder (PTSD)? If conventional therapies haven’t worked, you’re not alone. At Field Trip Health, we specialize in innovative treatment options for treatment-resistant mental health conditions. MDMA therapy in Canada is an emerging, research-backed option that offers promising results—especially for those with PTSD who haven’t responded to talk therapy or medications.

MDMA-assisted psychotherapy is a groundbreaking therapy that combines controlled doses of MDMA with structured therapy sessions. This approach helps reduce fear, build trust, and deepen emotional insight. In Phase 3 clinical trials conducted by MAPS (Multidisciplinary Association for Psychedelic Studies), 88% of participants experienced meaningful improvement, and 67% no longer met the criteria for PTSD. These results are unmatched by conventional care. At Field Trip Health, our MDMA therapy clinic in Canada offers access to this innovative and highly effective treatment.

Consultations are available now.

Consultations for MDMA therapy in Canada are available now. Book your free discovery call with one of our experienced nurses. We’ll answer your questions, discuss your eligibility, and help you take the next step toward healing with MDMA-assisted therapy.

How does MDMA therapy work?

MDMA-assisted therapy combines a structured dose of MDMA with psychotherapy to reduce fear and emotional reactivity. This allows individuals—especially those with PTSD or treatment-resistant mental health conditions—to process traumatic memories in a supported and non-threatening way. At Field Trip Health, our experienced therapists and clinicians monitor every session for safety and effectiveness.

While MDMA remains a controlled substance in Canada, access is possible under Health Canada’s Special Access Program for treatment-resistant PTSD and related conditions. If you're eligible, we help you request access and guide you through every step.

Who is MDMA therapy for?

✔ Individuals in Canada with treatment-resistant PTSD

✔ People with PTSD who haven’t responded to traditional therapy or medication

✔ Those interested in psychedelic-assisted psychotherapy for trauma and anxiety

Client testimonials

How long does MDMA-assisted therapy take?

Each MDMA therapy session typically lasts 6 to 8.5 hours and is conducted by trained MDMA therapists. These longer sessions allow for deep therapeutic breakthroughs. Your personalized treatment plan will also include preparatory sessions and integration therapy to ensure lasting results.

MDMA PTSD therapy in Canada often follows a structured series of appointments, designed around your needs and approved through Health Canada where required.

What results can I expect from MDMA therapy?

MDMA-assisted therapy has shown some of the most promising results in psychedelic research. A 2021 Phase 3 clinical trial by the Multidisciplinary Association for Psychedelic Studies (MAPS) found that 88% of participants saw meaningful symptom relief, and 67% no longer met the criteria for PTSD.

These outcomes significantly outperform traditional PTSD treatments. MDMA therapy Canada programs offer new hope for those who have felt stuck or hopeless.

It’s important to note that individual responses vary. 

Is there downtime after MDMA therapy?

Yes, each MDMA therapy session lasts 6–8 hours. Due to the effects of MDMA, you must arrange transportation home and cannot drive afterward. Many clients choose to take the following day off for rest and integration. This is especially helpful for processing your experience and making the most of your MDMA-assisted psychotherapy session.

TAKE THE NEXT STEP – REQUEST A DISCOVERY CALL

If you’re considering MDMA therapy in Canada, start with a free discovery call. Our expert nursing team will help you understand eligibility, answer your questions, and guide you through the next steps.
Book a call today and learn more about this life-changing MDMA therapy service.

*Individual results may vary.

Frequently asked questions.

MDMA-assisted psychotherapy goes beyond traditional talk therapy. MDMA gives way to reduced fear and anxiety, as well as openness and empathy. This can help you break barriers hindering your pathway toward relief.

In a 2021 controlled phase 3 clinical trial by MAPS, the Multi-Disciplinary Association of Psychedelic Studies, 88% of patients had a clinically meaningful symptom improvement, with 67% no longer having PTSD.

In a 2023 controlled phase 3 clinical trial, researchers reported that participants with moderate to severe PTSD had decreased PTSD symptoms and functional impairments, with the treatment being well-tolerated. Minimal symptoms included overall mild increases in blood pressure and heart rate, which subsided after treatment.

This depends on the specific medication. During your 50-minute medical consultation, issues regarding current medications will be addressed and discussed.

We work closely with each client to ensure applicable insurance is used where possible. Each treatment is performed by licensed Therapists (Psychotherapists, Clinical Counselors, and Social Workers), which are usually insurance-eligible under most benefits plans. We suggest verifying your specific coverage directly with your insurance provider before booking your treatment.

Your eligibility is determined in your medical consultation. During this time, we will go through your medical history and health status, which can provide information regarding your specific eligibility. The main contradictions to this type of treatment include psychosis, pregnancy, and uncontrolled hypertension.

All side effects are temporary and include nausea, muscle tension, feeling cold or sweating, and changes in heart rate and blood pressure. Our clinical team monitors you for any of these effects throughout your session. If you’re likely to feel nauseous, you may be provided with anti-nausea medicine before starting your therapeutic experience.

MDMA is not legal for general public use and is currently classified as a controlled substance in Canada. However, under Health Canada’s Special Access Program, MDMA-assisted psychotherapy may be approved for individuals with treatment-resistant PTSD or severe anxiety when conventional therapies have failed.

Unlike recreational forms of MDMA—often referred to as ecstasy or molly—MDMA therapy in Canada is provided in medical settings by trained professionals, including licensed MDMA therapists and healthcare practitioners. Clients receive a carefully monitored dose of MDMA as part of a broader psychedelic-assisted therapy program that includes preparation and integration support.

There is growing interest in MDMA therapy and other psychedelic drugs like psilocybin and ketamine, as clinical trials continue to show promising results in treating a range of mental health conditions, including PTSD and anxiety.

en_CAEN

Start your personalized assisted-psychotherapy journey today.